| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.49B | — | +11.6% |
| R&D Expense | $17.8M | — | -6.8% |
| SG&A Expense | $215.9M | — | +17.2% |
| Operating Income | $386.1M | — | +38.8% |
| Pre-tax Income | $355.8M | — | +54.5% |
| Income Tax | $95.9M | — | +10.2% |
| Net Income | $260.5M | — | +83.5% |
| EPS (Basic) | $0.65 | — | +91.2% |
| EPS (Diluted) | $0.64 | — | +93.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $960.8M | -6.9% | -19.0% |
| Accounts Receivable | $1.20B | +6.0% | +4.5% |
| Inventory | $1.22B | +6.2% | +3.8% |
| Current Assets | $5.53B | -0.3% | +0.1% |
| Total Assets | $10.09B | -0.3% | +1.1% |
| Current Liabilities | $4.90B | -0.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $332.5M | — | -24.7% |
| Capital Expenditures | $55.6M | — | -10.0% |
| Investing Cash Flow | -$53.6M | — | +7.9% |
| Financing Cash Flow | -$350.9M | — | +4.1% |
| Free Cash Flow | $276.9M | — | -27.1% |
| -5.4% |
| Long-term Debt | $420.4M | -2.2% | -53.5% |
| Total Liabilities | $6.72B | +0.0% | -2.0% |
| Stockholders' Equity | $3.36B | -0.0% | +9.5% |